Literature DB >> 32059674

Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.

Daixi Ren1,2,3, Yuze Hua1,2,3, Boyao Yu1,2,3, Xin Ye2, Ziheng He2, Chunwei Li2, Jie Wang2, Yongzhen Mo2, Xiaoxu Wei2, Yunhua Chen2, Yujuan Zhou1, Qianjin Liao1, Hui Wang1, Bo Xiang1,2,3, Ming Zhou1,2,3, Xiaoling Li1,2,3, Guiyuan Li1,2,3, Yong Li4, Zhaoyang Zeng1,2,3, Wei Xiong5,6,7.   

Abstract

After publication of the article [1], authors found out that Fig. 1 was inadvertently replaced.

Entities:  

Year:  2020        PMID: 32059674     DOI: 10.1186/s12943-020-01148-y

Source DB:  PubMed          Journal:  Mol Cancer        ISSN: 1476-4598            Impact factor:   27.401


  1 in total

1.  Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study.

Authors:  Mohammed Safi; Mahmoud Al-Azab; Chenxing Jin; Dario Trapani; Salem Baldi; Salah Adlat; Aman Wang; Bashir Ahmad; Hamza Al-Madani; Xiu Shan; Jiwei Liu
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.